
Conference Coverage
about 2 hours ago
Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhDLatest Content

Why a Landmark Hepatitis D Drug May Not Be Enough on Its Own

Delgocitinib Cream Projected to Save US Health Plans Millions for Chronic Hand Eczema

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

New MINT Trial Analysis Favors Liberal Transfusion After MI

Shorts










Podcasts
Center on Health Equity & Access
All News

Closed-loop social care networks move beyond referrals, proving statewide scale can cut ED use and Medicaid costs while tracking real outcomes.

New cancer drugs reached patients fastest, but overall access timelines remained lengthy across the US, France, Germany, and Switzerland.

East Asian patients with generalized myasthenia gravis (gMG) saw meaningful nipocalimab benefits in a Vivacity-MG3 subgroup analysis.

A dermatology review proposes sorting patients with overlapping atopic dermatitis and alopecia areata into 3 immunophenotype-guided archetypes to select and sequence systemic therapy.

Anti-VEGF has maxed out in diabetic macular edema (DME), but Ang-2 and Wnt pathway approaches could target disease differently, said John Kitchens, MD.

CMS value-based payment models underrepresent Black, Hispanic, dual-eligible, and disadvantaged Medicare beneficiaries compared with the broader population.

Our August cover story from Evidence-Based Oncology.

Clinicians say workflow changes, not education alone, are closing screening and treatment gaps in cardio-kidney-metabolic (CKM) care.

These results provide support for a potential new standard of care in the relapsed/refractory setting.

Doug Francis of Rhythm Healthcare on what's driving respiratory and mobility care out of facilities and into patients' homes





















